drugset / Trial / NCT06171087

Emotions, Dopamine, Brain and Body

NCT06171087

Phase 4 Unknown 40 enrolled German Institute of Human Nutrition
RandomizedSequentialTriple-blindBasic science

Summary

The study will examine the influence of domperidon (20mg) on brain and hebavioral responses to emotional stimuli (videos) using fMRI

Timeline

Start
2023-08-01
Primary completion
2024-03-30
Completion
2024-09-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Domperidon Unknown 10 mg Oral

Indications

No indication recorded.